Elise Nassif Haddad
@NassifElise
Followers
649
Following
3K
Media
54
Statuses
988
Assistant Professor, Sarcoma Medical Oncology @MDAndersonNews . Views are mine. 🇫🇷
Houston, TX
Joined January 2019
✨🥳Finally published! Clinical and preliminary #translational data from the #neoadjuvant #immunotherapy trial in #sarcoma #DDLPS and #UPS. @MDAndersonNews @CrisyRoland @emilykeungMD @JenWargoMD @NeetaSomaiahMD Main results, a🪡🧵: https://t.co/humJrmnb0E
nature.com
Nature Cancer - Roland et al. report the results of a randomized, non-comparative phase 2 trial of neoadjuvant nivolumab or a combination of nivolumab and ipilimumab in patients with resectable...
12
21
96
Missing @bvantine1 at @ctosociety #ctos2025 He was always a great advocate for young people and especially aspiring physician scientists like me.
3
3
37
0
7
24
Our two superstar awardees this year! So well deserved!! Love seeing you together, great science to come from both your labs! #ctos2025
2
1
12
So happy that our new superstar ⭐️🌟 colleague Carlos Torrado joined our Sarcoma Medical Oncology at @MDAndersonNews Be ready to see him become a leading clinical investigator in our field #CTOS2025 Welcome to the team Carlos!!
Honored to share our Phase 1/2 data from MD Anderson at #CTOS2025 today 📊 • DR5 agonists demonstrated improved PFS compared with other therapies📈 • Stable disease with any tumor reduction (SD-ATR) was associated with improved PFS and OS and may be a meaningful surrogate
0
1
12
.@RobinL_Jones @royalmarsden presenting ChonDRAgon PhII registrational study of Ozekibart in conventional #chondrosarcoma #CTOS2025 - No approved systemic therapies - mPFS 5.5 mo, with 21.7% w/o prog @ 12 mo - Activity in both IDH-WT & mut - TRAE incl ~13% fatigue, ~6% hepatitis
1
10
24
#CTOS 2025 started paying respects to the great Dr. Brian Van Tine, who unfortunately left us way too early. Dr. Van Tine was always incredibly kind to me and all in my team and helped my career in many ways
0
5
19
Tumor reduction with a TEAD inhibitor for #EHE. Exciting early data from #sarcoma @DanaFarber superstar Dr Candace Haddox #CTOS2025
0
3
21
🥇So proud of @NassifElise for all the Research & Clinical work 📄 she's doing at @MDAndersonNews to improve the outcome of #sarcoma patients around the 🌎 #leiomyosarcoma #rarecancer #endcancer #sarcsm
https://t.co/wcftMXYC1N
2
2
16
#CTOS2025 is not only about great science, it's also a perfect opportunity for mentorship for trainees and young fellows! Don't miss the 🌅 Sunrise Mentorship Session on Nov 13, 7.00 am ( breakfast and coffee will be served ☕)! Check topics and mentors 🧑🏫on the graphic⬇️
2
18
35
Stephane Champiat! The Champion! @MDAndersonNews, #Targets25 !
Cancer Vaccines: Patrick Ott, Vinod P. Balachandran, Stephane Champiat, and June-Young Koh addressed this topic in a session at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. #Targets25 @TheVinodLab @champiatMD
1
2
16
The best 😍
Data from our study presented at #ESMO25 👉 2L therapy after failure of 1L 2G-TKIs in #CML 👫 276 patients 🔸Treatment switch due to side effects and/or resistance 🔸~60% response in patients with resistance 🔸3G-TKIs > 2G-TKIs #leusm #leukemia @OncoAlert @MDAndersonNews
1
0
2
Always so funny how you end up seeing your colleagues at meetings more than at home! @ANaing @MDAndersonNews #ESMO25
2
2
21
Data presented at #ESMO25 by Dr Mika Kontro on the Macrophage reprogrammer #bexmarilimab plus azacitidine in myelodysplastic syndrome (BEXMAB) @myESMO @OncoAlert @Daver_Leukemia @Dr_AmerZeidan
1
14
38
0
5
16
wonderful agenda for the #leiomysarcoma community in berlin🇩🇪 time to work on harmonized af lms care and future directions @ctosociety
0
7
20
Join me at #ESMO25 Berlin 🇩🇪 on Sunday October 19 where I will presenting our data 📈 on second line treatment after failure of frontline 2G-TKIs in chronic myeloid #leukemia #CML @OncoAlert @MDAndersonNews
4
6
36
Help me #EndCancer #EndSarcoma I am raising money to give sarcoma the boot once and for all. Please consider donating to support my efforts. Your donation (100%!) helps fund Groundbreaking research that will save lives around the world. https://t.co/lTU9OOoBs2
mdanderson.donordrive.com
The University of Texas MD Anderson Cancer Center, the global leader in cancer care. Novel discoveries at MD Anderson pave the way for new cancer therapies, making a difference in the outcomes of...
0
0
6